Want to see JP:3353 full AI Analyst Report?

Medical Ikkou Group Co., Ltd. (3353) Price & Analysis

1 Followers

3353 Stock Chart & Stats

¥2930.00

¥4.00(0.19%)

At close: Jan 08 4:00 PM EST

¥2930.00

¥4.00(0.19%)

Day’s Range― - ―

52-Week Range¥2,590.00 - ¥3,235.00

Previous CloseN/A

Volume1.00K

Average Volume (3M)1.91K

Market Cap

¥9.61B

Enterprise Value¥14.14K

Total Cash (Recent Filing)¥6.12B

Total Debt (Recent Filing)¥10.36B

Price to Earnings (P/E)7.1

Beta0.26

Next Earnings

Oct 09, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield4.31%

Share Statistics

EPS (TTM)338.74

Shares Outstanding3,770,000

10 Day Avg. Volume1,600

30 Day Avg. Volume1,913

Financial Highlights & Ratios

PEG Ratio0.73

Price to Book (P/B)0.73

Price to Sales (P/S)0.21

P/FCF Ratio52.19

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Improving Revenue GrowthThe company has maintained positive top-line momentum, with revenue growth improving materially across recent periods. Sustained expansion can support pharmacy scale, strengthen operating leverage over time, and provide a foundation for continued earnings growth.

Lower Financial LeverageDeleveraging reduces financial risk and improves flexibility for store investment, acquisitions, or other operating needs. Equity growth alongside assets also supports balance-sheet resilience, making the business less vulnerable to financing pressure.

Positive Free Cash FlowAlthough cash conversion is inconsistent, recurring positive free cash flow indicates that the business has generated cash after investment in every period presented. This provides a base for funding operations and reducing reliance on external financing.

Bears Say

Weak Cash ConversionVery weak conversion of accounting earnings into cash raises concerns about working-capital swings or ongoing investment requirements. If persistent, this could constrain reinvestment, dividends, and debt reduction despite reported profitability.

Low And Declining MarginsThin profitability leaves limited protection against reimbursement pressure, labor costs, or changes in pharmacy and service mix. The recent EBITDA margin decline suggests that revenue growth has not translated proportionally into operating profit.

Moderate Return On EquityStable but modest returns indicate consistent profitability without especially strong capital productivity. This may limit the company’s ability to compound value internally and suggests that growth could require more capital than higher-return healthcare operators.

3353 FAQ

What was Medical Ikkou Group Co., Ltd.’s price range in the past 12 months?

Medical Ikkou Group Co., Ltd. lowest stock price was ¥2590.00 and its highest was ¥3235.00 in the past 12 months.

What is Medical Ikkou Group Co., Ltd.’s market cap?

Medical Ikkou Group Co., Ltd.’s market cap is ¥9.61B.

When is Medical Ikkou Group Co., Ltd.’s upcoming earnings report date?

Medical Ikkou Group Co., Ltd.’s upcoming earnings report date is Oct 09, 2026 which is in 20 days.

How were Medical Ikkou Group Co., Ltd.’s earnings last quarter?

Medical Ikkou Group Co., Ltd. released its earnings results on Jul 10, 2026. The company reported ¥169.33 earnings per share for the quarter.

Is Medical Ikkou Group Co., Ltd. overvalued?

According to Wall Street analysts Medical Ikkou Group Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medical Ikkou Group Co., Ltd. pay dividends?

Medical Ikkou Group Co., Ltd. pays a Semiannually dividend of ¥60 which represents an annual dividend yield of 4.31%. See more information on Medical Ikkou Group Co., Ltd. dividends here

What is Medical Ikkou Group Co., Ltd.’s EPS estimate?

Medical Ikkou Group Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medical Ikkou Group Co., Ltd. have?

Medical Ikkou Group Co., Ltd. has 3,770,000 shares outstanding.

What happened to Medical Ikkou Group Co., Ltd.’s price movement after its last earnings report?

Medical Ikkou Group Co., Ltd. reported an EPS of ¥169.33 in its last earnings report. Following the earnings report the stock price went up 1.86%.

Which hedge fund is a major shareholder of Medical Ikkou Group Co., Ltd.?

Currently, no hedge funds are holding shares in JP:3353

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medical Ikkou Group Co., Ltd.

Medical Ikkou Group Co.,Ltd. is a Japanese enterprise primarily known for managing dispensing pharmacies across the nation. Beyond its extensive pharmacy operations, the company diversified its activities to include the management of various care facilities, such as nursing homes, outpatient nursing centers, and home-visit nursing care services. Its business portfolio also encompasses the wholesale of generic pharmaceuticals and real estate property rentals. Furthermore, the group is active in financial investments, including stakes in both listed and unlisted securities, and participates in merger and acquisition activities. The company currently oversees 93 dispensing pharmacy locations. Established in 1980, Medical Ikkou Group is headquartered in Tsu, Japan.